The DSS results of Kaplan–Meier analysis manifested that ARPC5 expression adverse to DSS in patients with BLCA, KIRC, KIRP, LCC, and LIHC, whereas positively correlated to DSS of LUSC, OV, SKCM, and STAD (Supplementary Figure S2). The gene discussed is ARPC5; the disease is bladder transitional cell carcinoma.